Eliyahu Sharon Kalif

EVP, Chief Financial Officer, Teva Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$20.7M

Companies

Latest trade

Jun 11, 2026

Companies

Teva PharmaceuticalsEVP, Chief Financial Officer −$20.7M

Trades

TEVA Sold 106,563 shares at $34.10 · planned $3.6M Jun 11

TEVA Sold 153,251 shares at $35.61 · planned $5.5M May 14

TEVA Sold 345,810 shares at $33.64 · planned $11.6M Feb 26

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.